Critical

Severe drug-induced liver injury (DILI)

Hepatotoxicity · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Drugs and herbal/supplement products can cause severe hepatocellular or cholestatic injury, occasionally progressing to acute liver failure. Stopping the culprit, supportive care, and applying transplant criteria for failure are key.

Assessment

Investigations

  • Detailed drug/supplement history (antibiotics, anti-TB, paracetamol, herbals)
  • LFTs (pattern), coagulation/INR, glucose, ammonia
  • Exclude viral/autoimmune/ischaemic causes; paracetamol level

Management

  • Stop the suspected culprit drug(s)
  • N-acetylcysteine for paracetamol-related (and considered in non-paracetamol acute liver failure)
  • Supportive care; monitor INR, glucose and conscious level
  • Apply Kings College criteria and refer early to a liver/transplant unit if failing
  • Avoid further hepatotoxins; manage complications of liver failure

Drugs & doses

Stop culprit drug
N-acetylcysteine
Supportive care

Disposition

Hepatology; transplant unit if failing.

Stop the drug and watch the INR and conscious level - a rising INR with encephalopathy in DILI means refer to a transplant centre urgently.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.